AKTX
Akari Therapeutics
AKTX
AKTX
19 hedge funds and large institutions have $51M invested in Akari Therapeutics in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Holders
19
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$606K | |
| 2 | +$36.2K | |
| 3 | +$18K | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$16K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$10.6K |
Top Sellers
| 1 | -$1.77M | |
| 2 | -$743K | |
| 3 | -$376K | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$118K |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$62.5K |